Your browser doesn't support javascript.
loading
RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642 in SAMP8 mice.
Pawar, Shrikant; Bellver-Sanchis, Aina; Griñán-Ferré, Christian.
Affiliation
  • Pawar S; Department of Genetics, Yale University, New Haven, CT, USA.
  • Bellver-Sanchis A; Department of Pharmacology and Therapeutic Chemistry, Institut de Neurociències-Universitat de Barcelona, Avda. Joan XXIII, 27, Barcelona 08028, Spain.
  • Griñán-Ferré C; Department of Pharmacology and Therapeutic Chemistry, Institut de Neurociències-Universitat de Barcelona, Avda. Joan XXIII, 27, Barcelona 08028, Spain.
Data Brief ; 36: 107114, 2021 Jun.
Article in En | MEDLINE | ID: mdl-34307805
ABSTRACT
Growing evidence demonstrates the epigenetic modulation as a key event in Alzheimer's disease (AD) pathology. Furthermore, recent data suggests that the epigenetic regulation by the methyltransferase G9a is a crucial mechanism involved in learning and memory formation. Taking this into account, we hereby provide genomics data from pharmacological intervention with UNC0642, a potent and selective G9a/GLP in SAMP8 mice, a model of Alzheimer's disease (AD). We have generated novel RNA-seq and miRNA-seq data for three groups, healthy SAMR1, SAMP8 control and SAMP8 treated with UNC0642 (5 mg/Kg). Thus, the new data can be used to find miRNA regulation, and the mRNA's modified in AD under G9a/GLP inhibition.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Data Brief Year: 2021 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Data Brief Year: 2021 Document type: Article Affiliation country: Estados Unidos